Performance of Risk Assessment Models in Critically Ill Patients With VTE Receiving Pharmacologic Thromboprophylaxis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Performance of risk assessment models for venous thromboembolism in critically ill patients receiving pharmacologic thromboprophylaxis: a post hoc analysis of the PREVENT trial
Chest 2024 Sep 02;[EPub Ahead of Print], HM Al-Dorzi, H Arishi, FM Al-Hameed, KE Burns, S Mehta, J Jose, SJ Alsolamy, S Ann I Abdukahil, LY Afesh, MS Alshahrani, Y Mandourah, GA Almekhlafi, M Almaani, A Al Bshabshe, S Finfer, Z Arshad, I Khalid, Y Mehta, A Gaur, H Hawa, H Buscher, H Lababidi, A Al Aithan, A Al-Dawood, YM ArabiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.